Cefminox

Chemical compound
  • J01DC12 (WHO)
Legal statusLegal status
  • In general: ℞ (Prescription only)
Identifiers
  • (6R,7S)-7-(((((2S)-2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
CAS Number
  • 84305-41-9 checkY
PubChem CID
  • 71141
ChemSpider
  • 64286 ☒N
UNII
  • PW08Y13465
KEGG
  • D07642 checkY
ChEBI
  • CHEBI:135817
ChEMBL
  • ChEMBL1276342 ☒N
Chemical and physical dataFormulaC16H21N7O7S3Molar mass519.57 g·mol−13D model (JSmol)
  • Interactive image
  • O=C2N1/C(=C(\CS[C@@H]1[C@]2(OC)NC(=O)CSC[C@H](C(=O)O)N)CSc3nnnn3C)C(=O)O
InChI
  • InChI=1S/C16H21N7O7S3/c1-22-15(19-20-21-22)33-4-7-3-32-14-16(30-2,13(29)23(14)10(7)12(27)28)18-9(24)6-31-5-8(17)11(25)26/h8,14H,3-6,17H2,1-2H3,(H,18,24)(H,25,26)(H,27,28)/t8-,14-,16+/m1/s1 ☒N
  • Key:JSDXOWVAHXDYCU-VXSYNFHWSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Cefminox (INN) is a second-generation cephalosporin antibiotic.[1][2]

Spectrum

Cefminox is a broad-spectrum, bactericidal cephalosporin antibiotic. It is especially effective against Gram-negative and anaerobic bacteria. [citation needed]The following represents MIC data for a few medically significant microorganisms.

  • Clostridium difficile: 2 - 4 μg/ml
  • Escherichia coli: 0.125 - 16 μg/ml
  • Pseudomonas aeruginosa: 256 μg/ml[3]

References

  1. ^ Torres AJ, Valladares LD, Jover JM, Sánchez-Pernaute A, Frías J, Carcas AJ, et al. (September 2000). "Cefminox versus metronidazole plus gentamicin intra-abdominal infections: a prospective randomized controlled clinical trial". Infection. 28 (5): 318–22. doi:10.1007/s150100070027. PMID 11073141. S2CID 41555982.
  2. ^ US 8497086, "Reaction Medium For Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteria", issued 20 July 2013, assigned to Biomereux 
  3. ^ "Cefminox sodium Susceptibility and Minimum Inhibitory Concentration (MIC) Data" (PDF). www.toku-e.com.
  • v
  • t
  • e
Antibacterials active on the cell wall and envelope (J01C-J01D)
Beta-lactams
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases)
Penicillins (Penams)
Narrow
spectrum
β-lactamase sensitive
(1st generation)
β-lactamase resistant
(2nd generation)
Extended
spectrum
Aminopenicillins (3rd generation)
Carboxypenicillins (4th generation)
Ureidopenicillins (4th generation)
Other
Carbapenems / Penems
Cephems
Cephalosporins
Cephamycins
Carbacephems
1st generation
2nd generation
3rd generation
4th generation
5th generation
Siderophore
Veterinary
Monobactams
β-lactamase inhibitors
Combinations
Polypeptides
Glycopeptides
Lipoglycopeptides
Lipopeptides
Polymyxins
Other
  • Inhibits PG elongation and crosslinking: Ramoplanin§
Intracellular
Other
Stub icon

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e